O	0	10	Expression	Expression	NN	B-NP
O	10	11	,	,	,	O
O	12	22	regulation	regulation	NN	B-NP
O	22	23	,	,	,	O
O	24	27	and	and	CC	O
O	28	36	function	function	NN	B-NP
O	37	39	of	of	IN	B-PP
O	40	43	IGF	IGF	NN	B-NP
O	43	44	-	-	HYPH	B-NP
O	44	45	1	1	CD	I-NP
O	45	46	,	,	,	O
O	47	50	IGF	IGF	NN	B-NP
O	50	51	-	-	HYPH	I-NP
O	51	53	1R	1R	NN	I-NP
O	53	54	,	,	,	O
O	55	58	and	and	CC	O
O	59	62	IGF	IGF	NN	B-NP
O	62	63	-	-	HYPH	B-NP
O	63	64	1	1	CD	I-NP
O	65	72	binding	binding	NN	I-NP
O	73	81	proteins	protein	NNS	I-NP
O	82	84	in	in	IN	B-PP
B-Multi-tissue_structure	85	90	blood	blood	NN	B-NP
I-Multi-tissue_structure	91	98	vessels	vessel	NNS	I-NP
O	98	99	.	.	.	O

O	100	103	The	The	DT	B-NP
B-Multi-tissue_structure	104	112	vascular	vascular	JJ	I-NP
O	113	120	insulin	insulin	NN	I-NP
O	120	121	-	-	HYPH	B-NP
O	121	125	like	like	JJ	I-NP
O	126	132	growth	growth	NN	I-NP
O	133	139	factor	factor	NN	I-NP
O	140	141	(	(	(	O
O	141	144	IGF	IGF	NN	B-NP
O	144	145	)	)	)	O
O	145	146	-	-	HYPH	B-NP
O	146	147	1	1	CD	I-NP
O	148	154	system	system	NN	I-NP
O	155	163	includes	include	VBZ	B-VP
O	164	167	the	the	DT	B-NP
O	168	172	IGFs	IGF	NNS	I-NP
O	172	173	,	,	,	O
O	174	177	the	the	DT	B-NP
O	178	181	IGF	IGF	NN	I-NP
O	181	182	-	-	HYPH	B-NP
O	182	183	1	1	CD	I-NP
O	184	192	receptor	receptor	NN	I-NP
O	193	194	(	(	(	O
O	194	197	IGF	IGF	NN	B-NP
O	197	198	-	-	HYPH	B-NP
O	198	200	1R	1R	NN	I-NP
O	200	201	)	)	)	O
O	201	202	,	,	,	O
O	203	206	and	and	CC	O
O	207	215	multiple	multiple	JJ	B-NP
O	216	223	binding	binding	NN	I-NP
O	224	232	proteins	protein	NNS	I-NP
O	232	233	.	.	.	O

O	234	238	This	This	DT	B-NP
O	239	245	growth	growth	NN	I-NP
O	246	252	factor	factor	NN	I-NP
O	253	259	system	system	NN	I-NP
O	260	266	exerts	exert	VBZ	B-VP
O	267	275	multiple	multiple	JJ	B-NP
O	276	287	physiologic	physiologic	JJ	I-NP
O	288	295	effects	effect	NNS	I-NP
O	296	298	on	on	IN	B-PP
O	299	302	the	the	DT	B-NP
B-Anatomical_system	303	314	vasculature	vasculature	NN	I-NP
O	315	322	through	through	IN	B-PP
O	323	327	both	both	CC	B-NP
B-Anatomical_system	328	337	endocrine	endocrine	JJ	I-NP
O	338	341	and	and	CC	I-NP
B-Anatomical_system	342	351	autocrine	autocrine	JJ	I-NP
I-Anatomical_system	351	352	/	/	SYM	I-NP
I-Anatomical_system	352	361	paracrine	paracrine	JJ	I-NP
O	362	372	mechanisms	mechanism	NNS	I-NP
O	372	373	.	.	.	O

O	374	377	The	The	DT	B-NP
O	378	385	effects	effect	NNS	I-NP
O	386	388	of	of	IN	B-PP
O	389	392	IGF	IGF	NN	B-NP
O	392	393	-	-	HYPH	B-NP
O	393	394	1	1	CD	I-NP
O	395	398	are	be	VBP	B-VP
O	399	407	mediated	mediate	VBN	I-VP
O	408	419	principally	principally	RB	B-ADVP
O	420	427	through	through	IN	B-PP
O	428	431	the	the	DT	B-NP
O	432	435	IGF	IGF	NN	I-NP
O	435	436	-	-	HYPH	B-NP
O	436	438	1R	1R	NN	I-NP
O	439	442	but	but	CC	O
O	443	446	are	be	VBP	B-VP
O	447	456	modulated	modulate	VBN	I-VP
O	457	459	by	by	IN	B-PP
O	460	467	complex	complex	JJ	B-NP
O	468	480	interactions	interaction	NNS	I-NP
O	481	485	with	with	IN	B-PP
O	486	494	multiple	multiple	JJ	B-NP
O	495	498	IGF	IGF	NN	I-NP
O	499	506	binding	binding	NN	I-NP
O	507	515	proteins	protein	NNS	I-NP
O	516	520	that	that	IN	B-SBAR
O	521	531	themselves	themselves	PRP	B-NP
O	532	535	are	be	VBP	B-VP
O	536	545	regulated	regulate	VBN	I-VP
O	546	548	by	by	IN	B-PP
O	549	564	phosphorylation	phosphorylation	NN	B-NP
O	564	565	,	,	,	O
O	566	577	proteolysis	proteolysis	NN	B-NP
O	577	578	,	,	,	O
O	579	593	polymerization	polymerization	NN	B-NP
O	593	594	,	,	,	O
O	595	598	and	and	CC	O
B-Cell	599	603	cell	cell	NN	B-NP
O	604	606	or	or	CC	I-NP
B-Cellular_component	607	613	matrix	matrix	NN	I-NP
O	614	625	association	association	NN	I-NP
O	625	626	.	.	.	O

O	627	633	During	During	IN	B-PP
O	634	637	the	the	DT	B-NP
O	638	642	last	last	JJ	I-NP
O	643	649	decade	decade	NN	I-NP
O	649	650	,	,	,	O
O	651	652	a	a	DT	B-NP
O	653	664	significant	significant	JJ	I-NP
O	665	669	body	body	NN	I-NP
O	670	672	of	of	IN	B-PP
O	673	681	evidence	evidence	NN	B-NP
O	682	685	has	have	VBZ	B-VP
O	686	697	accumulated	accumulate	VBN	I-VP
O	697	698	,	,	,	O
O	699	709	indicating	indicate	VBG	B-VP
O	710	714	that	that	IN	B-SBAR
O	715	725	expression	expression	NN	B-NP
O	726	728	of	of	IN	B-PP
O	729	732	the	the	DT	B-NP
O	733	743	components	component	NNS	I-NP
O	744	746	of	of	IN	B-PP
O	747	750	the	the	DT	B-NP
O	751	754	IGF	IGF	NN	I-NP
O	755	761	system	system	NN	I-NP
O	762	765	are	be	VBP	B-VP
O	766	775	regulated	regulate	VBN	I-VP
O	776	778	by	by	IN	B-PP
O	779	787	multiple	multiple	JJ	B-NP
O	788	795	factors	factor	NNS	I-NP
O	795	796	,	,	,	O
O	797	806	including	include	VBG	B-PP
O	807	813	growth	growth	NN	B-NP
O	814	821	factors	factor	NNS	I-NP
O	821	822	,	,	,	O
O	823	832	cytokines	cytokine	NNS	B-NP
O	832	833	,	,	,	O
O	834	846	lipoproteins	lipoprotein	NNS	B-NP
O	846	847	,	,	,	O
O	848	856	reactive	reactive	JJ	B-NP
O	857	863	oxygen	oxygen	NN	I-NP
O	864	871	species	specie	NNS	I-NP
O	871	872	,	,	,	O
O	873	876	and	and	CC	O
O	877	888	hemodynamic	hemodynamic	JJ	B-NP
O	889	895	forces	force	NNS	I-NP
O	895	896	.	.	.	O

O	897	899	In	In	IN	B-PP
O	900	908	addition	addition	NN	B-NP
O	908	909	,	,	,	O
O	910	915	cross	cross	AFX	B-NP
O	915	916	-	-	HYPH	I-NP
O	916	920	talk	talk	NN	B-NP
O	921	928	between	between	IN	B-PP
O	929	932	the	the	DT	B-NP
O	933	936	IGF	IGF	NN	I-NP
O	937	943	system	system	NN	I-NP
O	944	947	and	and	CC	O
O	948	953	other	other	JJ	B-NP
O	954	960	growth	growth	NN	I-NP
O	961	968	factors	factor	NNS	I-NP
O	969	972	and	and	CC	O
O	973	981	integrin	integrin	NN	B-NP
O	982	991	receptors	receptor	NNS	I-NP
O	992	995	has	have	VBZ	B-VP
O	996	1000	been	be	VBN	I-VP
O	1001	1013	demonstrated	demonstrate	VBN	I-VP
O	1013	1014	.	.	.	O

O	1015	1020	There	There	EX	B-NP
O	1021	1023	is	be	VBZ	B-VP
O	1024	1036	accumulating	accumulate	VBG	I-VP
O	1037	1045	evidence	evidence	NN	B-NP
O	1046	1048	of	of	IN	B-PP
O	1049	1050	a	a	DT	B-NP
O	1051	1055	role	role	NN	I-NP
O	1056	1059	for	for	IN	B-PP
O	1060	1063	IGF	IGF	NN	B-NP
O	1063	1064	-	-	HYPH	B-NP
O	1064	1065	1	1	CD	I-NP
O	1066	1068	in	in	IN	B-PP
O	1069	1077	multiple	multiple	JJ	B-NP
B-Multi-tissue_structure	1078	1086	vascular	vascular	JJ	I-NP
O	1087	1098	pathologies	pathology	NNS	I-NP
O	1098	1099	,	,	,	O
O	1100	1109	including	include	VBG	B-PP
O	1110	1125	atherosclerosis	atherosclerosis	NN	B-NP
O	1125	1126	,	,	,	O
O	1127	1139	hypertension	hypertension	NN	B-NP
O	1139	1140	,	,	,	O
O	1141	1151	restenosis	restenosis	NN	B-NP
O	1151	1152	,	,	,	O
O	1153	1165	angiogenesis	angiogenesis	NN	B-NP
O	1165	1166	,	,	,	O
O	1167	1170	and	and	CC	O
O	1171	1179	diabetic	diabetic	JJ	B-NP
B-Multi-tissue_structure	1180	1188	vascular	vascular	JJ	I-NP
O	1189	1196	disease	disease	NN	I-NP
O	1196	1197	.	.	.	O

O	1198	1202	This	This	DT	B-NP
O	1203	1209	review	review	NN	I-NP
O	1210	1214	will	will	MD	B-VP
O	1215	1222	discuss	discuss	VB	I-VP
O	1223	1226	the	the	DT	B-NP
O	1227	1237	regulation	regulation	NN	I-NP
O	1238	1240	of	of	IN	B-PP
O	1241	1251	expression	expression	NN	B-NP
O	1252	1254	of	of	IN	B-PP
O	1255	1258	IGF	IGF	NN	B-NP
O	1258	1259	-	-	HYPH	B-NP
O	1259	1260	1	1	CD	I-NP
O	1260	1261	,	,	,	O
O	1262	1265	IGF	IGF	NN	B-NP
O	1265	1266	-	-	HYPH	I-NP
O	1266	1268	1R	1R	NN	I-NP
O	1268	1269	,	,	,	O
O	1270	1273	and	and	CC	O
O	1274	1277	IGF	IGF	NN	B-NP
O	1278	1285	binding	binding	NN	I-NP
O	1286	1294	proteins	protein	NNS	I-NP
O	1295	1297	in	in	IN	B-PP
O	1298	1301	the	the	DT	B-NP
B-Anatomical_system	1302	1313	vasculature	vasculature	NN	I-NP
O	1314	1317	and	and	CC	O
O	1318	1327	summarize	summarize	VBP	B-VP
O	1328	1336	evidence	evidence	NN	B-NP
O	1337	1348	implicating	implicate	VBG	B-VP
O	1349	1360	involvement	involvement	NN	B-NP
O	1361	1363	of	of	IN	B-PP
O	1364	1368	this	this	DT	B-NP
O	1369	1375	system	system	NN	I-NP
O	1376	1378	in	in	IN	B-PP
B-Multi-tissue_structure	1379	1387	vascular	vascular	JJ	B-NP
O	1388	1396	diseases	disease	NNS	I-NP
O	1396	1397	.	.	.	O

